Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9006285 Therapeutic agent for hepatitis C

Patent 9006285 was granted and assigned to Mochida Pharmaceutical on April, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Mochida Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

April 14, 2015

Patent Application Number

13121645

Date Filed

September 30, 2009

Patent Citations Received

US Patent 11690820 Methods of treating mixed dyslipidemia

0

US Patent 11986452 Methods of reducing the risk of heart failure

0

US Patent 11712429 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity

0

US Patent 11712428 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity

0

Patent Primary Examiner

Patent abstract

Disclosed is a novel therapeutic means against interferon-resistant hepatitis C. Specifically disclosed are: a pharmaceutical composition for treating interferon-resistant hepatitis C, which is characterized by comprising at least one component selected from the group consisting of an ω-3 polyunsaturated fatty acid, a pharmaceutically acceptable salt of the fatty acid and an ester of the fatty acid as an active ingredient; and a method for utilizing the pharmaceutical composition.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9006285 Therapeutic agent for hepatitis C

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool